STOCK TITAN

Ellomay Capital Ltd. SEC Filings

ELLO NYSE

Welcome to our dedicated page for Ellomay Capital Ltd. SEC filings (Ticker: ELLO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Ellomay Capital Ltd.'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Ellomay Capital Ltd.'s regulatory disclosures and financial reporting.

Rhea-AI Summary

Ellomay Capital Ltd. (ELLO) reported strong headline results for the six months ended June 30, 2026, driven by the sale of its indirect stake in Dorad Energy. Revenues from ongoing operations were about €21.1 million, slightly above the prior year’s €20.1 million, mainly due to biogas activity in the Netherlands, while lower Spanish electricity prices and Italian PPAs weighed on some solar revenues.

The company recorded a net profit of €58.3 million, compared with a small loss a year earlier, but this was dominated by a €83.3 million profit from discontinued operations related to the Dorad sale. Continuing operations showed a loss of €25.0 million, largely reflecting substantial FX-driven finance expenses. EBITDA for the half-year rose sharply to €90.6 million from €6.1 million. Ellomay executed an early full repayment of its Series E debentures and ended June 2026 with cash and cash equivalents of €113.5 million plus €53.3 million of short-term deposits, and reported Net Financial Debt of about €50.9 million, with debenture covenants comfortably met.

Operationally, Ellomay advanced solar and storage projects in Italy, the USA and Spain, expanded biogas capacity in the Netherlands, and continued construction at the Manara pumped storage project in Israel, while noting potential schedule risks from ongoing regional hostilities and pending compensation and financing adjustments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.2%
Tags
current report
-
Rhea-AI Summary

Phoenix Financial Ltd., an Israeli entity, reports beneficial ownership of 97,964.06 Ordinary Shares of Ellomay Capital Ltd., representing 0.71% of the class, based on 13,783,230 Ordinary Shares outstanding as of August 2, 2026 (as reported on Bloomberg LP). The shares are Ellomay Ordinary Shares with par value NIS 10.00 per share.

As of July 31, 2026, these holdings were spread across Phoenix group subsidiaries, including 27,455.06 shares held by The Phoenix Investments House trust funds, 16,510 shares in Phoenix “nostro” accounts, 32,374 shares in a partnership for Israeli shares, and 21,625 shares in a partnership for investing in share indexes. Phoenix states that each subsidiary has independent management and makes its own voting and investment decisions, and it disclaims group status and beneficial ownership beyond actual pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Ellomay Capital Ltd. is the issuer of ordinary shares, par value NIS 10.00 per share, held under CUSIP M39927120. Menora Mivtachim Holdings Ltd. and Menora Mivtachim Pensions and Gemel Ltd., both organized in Israel, report their beneficial ownership in these shares.

As of July 31, 2026, Menora Mivtachim Pensions and Gemel Ltd., Menora Mivtachim Insurance Ltd., and Menora Mivtachim Vehistadrut Hamehandesim Nihul Kupot Gemel Ltd. each held 0 ordinary shares, representing 0% of Ellomay Capital’s outstanding ordinary shares. Voting and dispositive power for each reporting person is reported as 0. The percentage calculation is based on 13,783,230 ordinary shares outstanding as of August 2, 2026. The reporting entities note that many securities are held economically for the benefit of insurance policy holders, portfolio account owners, and members of provident and pension funds, and they disclaim beneficial ownership except to the extent of their pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Ellomay Capital director Ben Simon Dorit received an annual grant of 1,000 stock options on August 1, 2026 under the issuer's 1998 Share Option Plan for Non-Employee Directors. The options cover 1,000 Ordinary Shares, have an exercise price of 19.6000, first become exercisable on August 1, 2027, and expire on August 1, 2036, subject to her continued board service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ellomay Capital Ltd. director Odelya Ohayon received an annual grant of 1,000 stock options on August 1, 2026 under the 1998 Share Option Plan for Non-Employee Directors. The options cover 1,000 ordinary shares at an exercise price of 19.6000 per share, become exercisable on August 1, 2027, expire on August 1, 2036, and are subject to her continuing to serve on the board on the exercisability date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ellomay Capital Ltd. director Daniel Vaknin received an annual grant of 1,000 stock options on August 1, 2026 under the Issuer's 1998 Share Option Plan for Non-Employee Directors. The options have a $19.60 exercise price, become exercisable August 1, 2027, are subject to his continued board service on that date, and expire August 1, 2036, leaving him with 1,000 options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Ellomay Capital Ltd. director Gilad Mamlok received an annual grant of stock options on August 1, 2026 under the 1998 Share Option Plan for Non-Employee Directors. The award covers 1,000 options to buy 1,000 Ordinary Shares at an exercise price of 19.60 per share, becoming exercisable on August 1, 2027 and expiring on August 1, 2036, subject to his continued board service on the exercise date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Ellomay Capital Ltd. reported that on July 30, 2026, a 10 MW solar facility in Italy held through its 51%-owned Ellomay Solar Italy Fifteen S.r.l. was successfully connected to the Italian national grid and began generating electricity. The plant is located in the Piemonte Region in northern Italy and has an expected P50 annual production of approximately 16.5 GWh. Management notes that actual results may differ from these expectations due to factors such as weather, electricity prices and demand, regulatory changes, financing conditions, operational disruptions, geopolitical conflicts and broader economic conditions in its main markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

O.Y. Nofar Energy Ltd., together with Yannay Group Ltd. and Ofer Yannay, reports updated beneficial ownership of 10,340,946 Ordinary Shares of Ellomay Capital Ltd., representing 75.0% of the Issuer’s 13,783,230 Ordinary Shares outstanding as of July 31, 2026.

On July 29, 2026, Nofar acquired an additional 4,022,000 Ordinary Shares, about 29.2% of Ellomay’s outstanding shares, from ten Israeli qualified investors in a share-for-share Exchange Transaction, issuing 1,363,458 newly issued Nofar ordinary shares at an exchange ratio of 0.339 Nofar share per Ellomay share, with no cash paid. The investment is intended to acquire control and serve as a long-term holding; Nofar is entitled to nominate up to four directors and has already placed two on the board. For six months after July 29, 2026, Nofar agreed not to enter into a more favorable Superior Exchange Transaction for other Ellomay shareholders unless it compensates the current counterparties to match any improved exchange ratio.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Ellomay Capital Ltd. is the subject of an amended Schedule 13G filing by Yelin Lapidot Holdings Management Ltd., its subsidiaries and principals. The reporting group states beneficial ownership of 35,757 Ordinary Shares, equal to 0.26% of Ellomay’s Ordinary Shares outstanding, based on 13,783,230 shares outstanding as of July 30, 2026.

The shares are held for mutual and provident funds managed by wholly owned subsidiaries of Yelin Lapidot Holdings, including 31,457 shares (0.23%) in mutual funds and 4,300 shares (0.03%) in provident funds. The subsidiaries make independent voting and investment decisions, and economic interest resides with fund members. Yelin Lapidot Holdings, Dov Yelin, and Yair Lapidot each disclaim beneficial ownership of these securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership

FAQ

How many Ellomay Capital Ltd. (ELLO) SEC filings are available on StockTitan?

StockTitan tracks 76 SEC filings for Ellomay Capital Ltd. (ELLO), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Ellomay Capital Ltd. (ELLO)?

The most recent SEC filing for Ellomay Capital Ltd. (ELLO) was filed on August 18, 2026.